Arcellx (ACLX) Asset Utilization Ratio (2023 - 2025)
Arcellx's quarterly Asset Utilization Ratio came in at 0.04 in Q4 2025, down 75.81% year-on-year from 0.15 in Q4 2024, and down 37.18% quarter-over-quarter from 0.06 in Q3 2025.
Arcellx has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.04 in Q4 2025.
- For the quarter ending Q4 2025, Asset Utilization Ratio fell 75.81% year-over-year to 0.04; the trailing twelve-month figure through Dec 2025 stood at 0.04 (down 75.81% YoY), and the FY2025 full-year result was 0.03, down 75.88% from the prior year.
- Asset Utilization Ratio for Q4 2025 stood at 0.04, down from 0.06 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.21 in Q3 2024, with the low at 0.04 in Q4 2025.
- Average Asset Utilization Ratio over 3 years is 0.11, with a median of 0.1 recorded in 2025.
- Year-over-year, Asset Utilization Ratio soared 329.06% in 2024 and plunged 75.81% in 2025.
- Tracing ACLX's Asset Utilization Ratio over 3 years: stood at 0.15 in 2023, then slipped by 4.6% to 0.15 in 2024, then sank by 75.81% to 0.04 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.04 (Q4 2025), 0.06 (Q3 2025), and 0.09 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.04 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | 0.09 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 0.15 |
| Sep 30, 2024 | 0.21 |
| Jun 30, 2024 | 0.19 |
| Mar 31, 2024 | 0.16 |
| Dec 31, 2023 | 0.15 |
| Sep 30, 2023 | 0.08 |
| Jun 30, 2023 | 0.05 |
| Mar 31, 2023 | 0.04 |